BioPort Anthrax Vaccine Production Data To Be Submitted To FDA By Mid-Oct.
Executive Summary
Anthrax vaccine manufacturer BioPort plans to submit data to FDA by Oct. 15 for approval of its renovated Lansing, Mich. plant.
You may also be interested in...
PhRMA Antibiotics Manufacturing Capability Review Requested By Thompson
The Pharmaceutical Research & Manufacturers of America will submit a review of antibiotics manufacturing capability to HHS Secretary Tommy Thompson by early next week, President Alan Holmer told a press briefing Oct. 26.
PhRMA Antibiotics Manufacturing Capability Review Requested By Thompson
The Pharmaceutical Research & Manufacturers of America will submit a review of antibiotics manufacturing capability to HHS Secretary Tommy Thompson by early next week, President Alan Holmer told a press briefing Oct. 26.
Bioterrorism Vaccines: Liability Limits, Federalization Under Consideration
The Biotechnology Industry Organization is urging Congress to limit the liability of manufacturers who enter the vaccine production business in the interest of preparedness against potential bioterrorism attacks.